GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » Short-Term Capital Lease Obligation

Egetis Therapeutics AB (OSTO:PLED BTA) Short-Term Capital Lease Obligation : kr0.00 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB Short-Term Capital Lease Obligation?

Egetis Therapeutics AB's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.00 Mil.

Egetis Therapeutics AB's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (kr0.00 Mil) to Dec. 2024 (kr2.80 Mil) but then declined from Dec. 2024 (kr2.80 Mil) to Mar. 2025 (kr0.00 Mil).

Egetis Therapeutics AB's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (kr1.60 Mil) to Dec. 2023 (kr2.20 Mil) and increased from Dec. 2023 (kr2.20 Mil) to Dec. 2024 (kr2.80 Mil).


Egetis Therapeutics AB Short-Term Capital Lease Obligation Historical Data

The historical data trend for Egetis Therapeutics AB's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Short-Term Capital Lease Obligation Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 1.50 1.60 2.20 2.80

Egetis Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 2.80 -

Egetis Therapeutics AB Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Egetis Therapeutics AB Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Industry
Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines